Oxcarbazepine
Product Images NDC 50090-5003

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 50090-5003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500905003)

This appears to be a label or packaging information for a medication or supplement. The product is identified with the code "No." followed by a series of alphanumeric characters. It is advised to store the product at a specific temperature expressed in degrees. The product comes in small tablets, with 33 being the quantity in a package. Unfortunately, there is not enough readable text to determine the name or purpose of the medication or supplement.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

FDA Label Image

Figure 1 (Oxcarbazepine 02)

This appears to be a survival analysis plot with the exit rate shown on the y-axis and time on the x-axis. The log-rank test was conducted and the p-value is shown as 0.0001. The plot appears to show data for a trial that took place from Day 2 to Day 11 with data for a placebo group.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

The text provides information on the seizure rate using Oxcarbazepine and Placebo treatments. A log-rank test was performed, resulting in a p-value of 0.046. The graph shows the number of days from the first dose to the first seizure in both treatment groups, with the x-axis representing time in days and the y-axis representing the number of patients experiencing a seizure. Therefore, this text is useful for analyzing the efficacy of Oxcarbazepine in preventing seizures.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

This is a survival analysis output of a log-rank test, which compares the survival of two treatment groups (HIGH and LOW) for an unknown event. The p-value is significant at 0.0001, indicating that there is a significant difference in survival between the two groups. The graph shows the percentage of individuals in each group still surviving at different time points (measured in days).*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

This is a survival analysis report for a treatment group that displays the exit rate over time, measured in days. The log-rank test resulted in a p-value of 0.0001, suggesting a significant difference in survival between the high and low treatment groups. However, further information about the treatment method and study design is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.